Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 5Colorectal Neoplasms 5Neoplasms 4Breast Neoplasms 4Stomatitis 3Neoplasm Metastasis 3Adenoma 3Urologic Neoplasms 2Stomach Neoplasms 2Mucositis 2Insulin Resistance 2Head and Neck Neoplasms 2Vulvodynia 1Urologic Diseases 1Urolithiasis 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Pain, Postoperative 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mobility Limitation 1Melanoma 1MRSA Colonization 1

Interventions

Metformin 149Clomiphene 51Letrozole 39Inositol 35Folic Acid 18Exercise 17Progesterone 15Ethinyl Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Tablets 9Spironolactone 9Cholecalciferol 9Triptorelin Pamoate 8Diet 8Vitamin D 7Thioctic Acid 7Menotropins 7Liraglutide 7Acupuncture Therapy 7drospirenone 6Ovidrel 6Gonadotropins 6Flutamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Polycystic Ovary Syndrome × Water × Clear all
NCT06155708 2025-01-22

Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome

McGill University

Phase NA Recruiting
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡